Oncopeptides
Ulrica Westermark currently serves as Biology Director at Oncopeptides AB (publ) since October 2020, overseeing the largest pre-clinical R&D platform and directing the development of assays while coordinating research activities with chemists. Previous roles include Senior Scientist at Affibody AB and Sobi - Swedish Orphan Biovitrum AB (publ), where Ulrica developed predictive assays and contributed to drug candidate development. Academic experience includes postdoctoral research at Karolinska Institutet focusing on microRNA and neuroblastoma, a PhD in Tumor Biology from Karolinska Institutet, and a research assistant position at Memorial Sloan-Kettering Cancer Center. Educational qualifications also feature Bachelor's and Master's degrees from Uppsala University in Medical Science and History of Science and Philosophy, respectively.
This person is not in the org chart
This person is not in any offices
Oncopeptides
2 followers
Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.